Chronic inflammatory demyelinative polyneuropathy

Handbook of Clinical Neurology

Volumn 115, Issue , 2013, Pages 403-413

  Said, Gérard ^a   Krarup, Christian ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOLOGIC FACTOR;

ARTICLE; CIDP; DEMYELINATIVE NEUROPATHIES; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; HUMAN; NERVE BIOPSY; NERVE CONDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; POEMS; POLYRADICULONEUROPATHY; TREATMENT;

CIDP; DEMYELINATIVE NEUROPATHIES; DIABETES; NERVE BIOPSY; NERVE CONDUCTION; POEMS; TREATMENT;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOLOGIC FACTORS; NEURAL CONDUCTION; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING;

EID: 84881522294     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52902-2.00022-9     Document Type: Chapter

References (84)

1. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force Research criteria for the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Neurology 1991, 41:617-618.
2. Albers J.W., Kelly J.J. Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989, 12:435-451.
3. Austin J.H. Recurrent polyneuropathies and their corticosteroid treatment. Brain 1958, 81:156-193.
4. Barohn R.J., Kissel J.T., Warmolts J.R., et al. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989, 46:878-888.
5. Bird S.J., Sladsky J.T. Corticosteroid-responsive dominantly inherited neuropathy in childhood. Neurology 1991, 41:437-439.
6. Bleasel A.F., Hawke S.H.B., Pollard J.D., et al. IgG monoclonal paraproteinaemia and peripheral neuropathy. J Neurol Neurosurg Psychiatry 1993, 56:52-57.
7. Bosboom W.M.J., Van den Berg L.H., Franssen H., et al. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain 2001, 124:2427-2438.
8. Bouchard C., Lacroix C., Planté V., et al. Clinicopathological findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999, 52:498-503.
9. Bragg J.A., Benatar M.G. Sensory nerve conduction slowing is a specific marker for CIDP. Muscle Nerve 2008, 38:1599-1603.
10. Bromberg M.B. Review of the evolution of electrodiagnostic criteria for chronic inflammatory demyelinating polyradicoloneuropathy. Muscle Nerve 2011, 43:780-794.
11. Bromberg M.B., Albers J.W. Patterns of sensory nerve conduction abnormalities in demyelinating and axonal peripheral nerve disorders. Muscle Nerve 1993, 16:262-266.
12. Chia L., Fernandez A., Lacroix C., et al. Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly: a retrospective review of 100 consecutive patients. Brain 1996, 119:1091-1098.
13. Cornblath D.R., Asbury A.K., Albers J.W., et al. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 1991, 41:617-618.
14. Di Trapani G., Carnevale A., Cioffi R.P., et al. Multiple sclerosis associated with peripheral demyelinating neuropathy. Clin Neuropathol 1996, 15:135-138.
15. Dispenzieri A. How I treat POEMS syndrome. Blood 2012, 14:5650-5658.
16. Duggins A.J., McLeod J.G., Pollard J.D., et al. Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain 1999, 122:1383-1390.
17. Dyck P.J., Lais A.C., Ohta M., et al. Chronic inflammatory polyradiculoneuropathy. Mayo Clinic Proc 1975, 50:621-637.
18. Ferreira A., Lozeron P., Lacroix C., et al. Sensory chronic inflammatory demyelinating polyneuropathy: a study of 28 cases with nerve biopsy. J. Neurol 2003, 250:149.
19. Fuglsang-Frederiksen A., Pugdahl K. Current status on electrodiagnostic standards and guidelines in neuromuscular disorders. Clin Neurophysiol 2011, 122:440-455.
20. Gabriel C.M., Gregson N.A., Hughes R.A. Anti-PMP22 antibodies in patients with inflammatory neuropathy. J Neuroimmunol 2000, 104:139-146.
21. Gorson K.C., Allam G., Ropper A.H. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology 1997, 48:321-328.
22. Gorson K.C., Ropper A.H., Weinberg D.H. Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 1999, 22:758-765.
23. Gorson K.C., Ropper A.H., Adelman L.S., et al. Influence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2000, 23:37-43.
24. Hahn A.F., Bolton C.F., Pillay N., et al. Plasma exchange therapy in CIDP. Brain 1996, 119:1055-1066.
25. Hahn A.F., Bolton C.F., Zochodne D., et al. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, cross-over study. Brain 1996, 119:1067-1077.
26. Hahn A.F., Hartung H.-P., Dyck P.J. Chronic inflammatory demyelinating polyneuropathy. Peripheral Neuropathy 2005, Vol. 2:2221-2253. Elsevier/Saunders, Philadelphia. 4th edn.
27. Haq R.U., Fries T.J., Pendlebury W.W., et al. Chronic inflammatory demyelinating polyradiculoneuropathy: a study of proposed electrodiagnostic and histologic criteria. Arch Neurol 2000, 57:1745-1750.
28. Harris W., Newcomb W.D. A case of relapsing interstitial hypertrophic polyneuritis. Brain 1929, 52:108-116.
29. Hattori N., Ichimura M., Aoki S., et al. Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood. J Neurol Sci 1998, 21:66-71.
30. Hattori N., Misu K., Koike H., et al. Age of onset influences clinical features of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2001, 184:57-63.
31. Ho T.W., Li C.Y., Cornblath D.R., et al. Patterns of recovery in the Guillain-Barré syndromes. Neurology 1997, 48:695-700.
32. Hughes R.A. Chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001, 50:281-282.
33. Hughes R., Bensa S., Willison H., et al. Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001, 50:195-201.
34. Isose S., Kuwabara S., Kokubun N., et al. Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies. J Peripher Nerv Syst 2009, 14:151-158.
35. Kaku D.A., England J.D., Sumner A.J. Distal accentuation of conduction slowing in polyneuropathy associated with antibodies to myelin-associated glycoprotein and sulphated glucuronyl paragloboside. Brain 1994, 117:941-947.
36. Kakuda T., Fukuda H., Tanitame K., et al. Diffusion tensor imaging of peripheral nerve in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a feasibility study. Neuroradiology 2011, 53:955-960.
37. Korinthenberg R. Chronic inflammatory demyelinating polyradiculoneuropathy in children and their response to treatment. Neuropediatrics 1999, 30:190-196.
38. Krarup C., Trojaborg W. Sensory pathophysiology in chronic acquired demyelinating neuropathy. Brain 1996, 119:257-270.
39. Kuwabara S., Ogawara K., Misawa S., et al. Distribution patterns of demyelination correlate with clinical profiles in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2002, 72:37-42.
40. Latov N. Diagnosis of CIDP. Neurology 2002, 59:S2-S6.
41. Lewis R.A., Sumner A.J. The electrodiagnostic distinctions between chronic familial and acquired demyelinative neuropathies. Neurology 1982, 32:592-596.
42. Lunn M.P., Manji H., Choudhary P.P., et al. Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England. J Neurol Neurosurg Psychiatry 1999, 66:677-680.
43. Maisonobe T., Chassande B., Verin M., et al. Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients. J Neurol Neurosurg Psychiatry 1996, 61:36-42.
44. Mathey E.K., Pollard J.D., Armati P.J. TNF alpha, IFN gamma and IL-2 Mrna expression in CIDP sural nerve biopsies. J Neurol Sci 1999, 163:47-52.
45. McCombe P.A., Pollard J.D., McLeod J.G. Chronic inflammatory demyelinating polyradiculoneuropathy. Brain 1987, 110:1617-1630.
46. McLeod J.G., Pollard J.D., Macaskill P., et al. Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol 1999, 46:910-913.
47. Melendez-Vasquez C., Redford J., Choudhary P.P., et al. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 1997, 73:124-134.
48. Mendell J.R., Barohn R.J., Freimer M.L. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 2001, 56:445-449. Working Group on Peripheral Neuropathy.
49. Mills K.R., Murray N.M. Neurophysiological evaluation of associated demyelinating peripheral neuropathy and multiple sclerosis: a case report. J Neurol Neurosurg Psychiatry 1986, 49:320-323.
50. Misawa S., Kuwabara S., Mori M., et al. Serum levels of tumor necrosis factor-alpha in chronic inflammatory demyelinating polyneuropathy. Neurology 2001, 56:666-669.
51. Misra V.P., Walker R.W. Acute-onset painful upper limb multifocal demyelinating motor neuropathy. J Neurol 2000, 247:949-954.
52. Molenaar D.S., Vermeulen M., de H.R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1998, 64:84-89.
53. Nagamatsu M., Mokuno K., Sugimura K., et al. Axonal and perikaryal involvement in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1999, 66:727-733.
54. Nevo Y., Pestronk A., Kornberg A.J., et al. Childhood chronic inflammatory demyelinating neuropathies: clinical course and long-term follow-up. Neurology 1996, 47:98-102.
55. Nicolas G., Maisonobe T., Le Forestier N., et al. Proposed revised electrophysiological criteria for chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2002, 25:26-30.
56. Notermans N.C., Wokke J.H.J., Franssen H., et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993, 56:1066-1071.
57. Oh S.J., Joy J.L., Kuruoglu R. Chronic sensory demyelinating neuropathy: chronic inflammatory demyelinating polyneuropathy presenting as a pure sensory neuropathy. J Neurol Neurosurg Psychiatry 1992, 55:677-680.
58. Ohkoshi N., Harada K., Nagata H., et al. Ataxic form of chronic inflammatory demyelinating polyradiculoneuropathy: clinical features and pathological study of the sural nerves. Eur Neurol 2001, 45:241-248.
59. Olney R.K. Consensus criteria for the diagnosis of partial conduction block. Muscle Nerve 1999, 22:S225-S229.
60. Planté-Bordeneuve V., Parman V., Mantel A., et al. The range of chronic demyelinating polyneuropathy of infancy: a clinico-pathological and genetic study of 15 unrelated cases. J Neurol 2001, 248:795-803.
61. Pollard J.D. Chronic inflammatory demyelinating polyradiculoneuropathy. Inflammatory Neuropathies: Baillière's Clinical Neurology 1994, Vol. 3:107-127. W.B. Saunders, London. J. McLeod (Ed.).
62. Prineas J.W. Pathology of Inflammatory Demyelinating Neuropathies. Baillière's Clinical Neurology 1994, Vol. 3. W.B. Saunders, London, pp. 1-24.
63. Prineas J.W., McLeod J.G. Chronic relapsing polyneuritis. J Neurol Sci 1976, 27:427-458.
64. Ryan M.M., Grattan-Smith P.J., Procopis P.G., et al. Childhood chronic inflammatory demyelinating polyneuropathy: clinical course and long-term outcome. Neuromuscul Disord 2000, 10:398-406.
65. Ruts L., Drenthen J., Jacobs B.C., et al. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology 2010, 74:1680-1686.
66. Said G., Bathien N., Cesaro P. Peripheral neuropathies and tremor. Neurology 1982, 32:480-485.
67. Said G., Saimot A.G., Lacroix C., et al. Neurological complications of HIV and AIDS. Major Problems in Neurology 1997, W.B. Saunders, London. C.P. Warlow, J. van Gijn (Eds.).
68. Sander H.W., Latov N. Research criteria for defining patients with CIDP. Neurology 2003, 60:S8-S15.
69. Sapperstein D.S., Katz J.S., Amato A.A., et al. Clinical spectrum of CIDP. Muscle Nerve 2001, 24:311-324.
70. Simmons Z., Albers J.W., Bromberg M., et al. Long-term follow-up of patients with chronic inflammatory demyelinating polyradiculoneuropathy, without and with monoclonal gammopathy. Brain 1995, 48:359-368.
71. Simmons Z., Wald J.J., Albers J.W. Chronic inflammatory demyelinating polyradiculoneuropathy in children: II. Long-term follow-up, with comparison to adults. Muscle Nerve 1997, 20:1569-1575.
72. Sladky J.T., Brown M.J., Berman P.H. Chronic inflammatory demyelinating polyneuropathy of infancy: a corticosteroid-responsive disorder. Ann Neurol 1986, 20:76-81.
73. Stewart J.D., McKelvey R., Durcan L., et al. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics. J Neurol Sci 1996, 142:59-64.
74. Stoll G., Hartung H.-P. The role of macrophages in degeneration and immune-mediated demyelination of the peripheral nervous system. Adv Neuroimmunol 1992, 2:163-179.
75. Thomas P.K., Lascelles R.G., Hallpike J.F., et al. Recurrent and chronic relapsing Guillain-Barré polyneuritis. Brain 1969, 92:589-606.
76. Thomas P.K., Walker R.W., Rudge P., et al. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelination. Brain 1987, 110:53-76.
77. Vallat J.M., Tabaraud F., Magy L., et al. Diagnostic value of nerve biopsy for atypical chronic inflammatory demyelinating polyneuropathy: evaluation of eight cases. Muscle Nerve 2003, 27:478-485.
78. Van den Bergh P.Y.K., Pieret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 2004, 29:565-574.
79. van Dijk G.W., Notermans N.C., Franssen H., et al. Development of weakness in patients with chronic inflammatory demyelinating polyneuropathy and only sensory symptoms at presentation: a long-term follow-up study. J Neurol 1999, 246:1134-1139.
80. Van Doorn P.A. Chronic inflammatory demyelinating polyneuropathy. Treatment of Neurological Disorders with Intravenous Immunoglobulins 2000, 43-56. Martin Dunitz, London. G. Said (Ed.).
81. Van Doorn P.A., Vermeulen M., Brand A., et al. Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: clinical and laboratory characteristics associated with improvement. Arch Neurol 1981, 48:217-220.
82. Van Es H.W., Van den Berg L.H., Franssen H., et al. Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy. Neurology 1997, 48:1218-1224.
83. Yan W.X., Taylor J., Andrias Kauba S., et al. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients. Ann Neurol 2000, 47:765-775.
84. Yuki N., Tagawa Y., Handa S. Autoantibodies to peripheral nerve glycosphingolipids SPG, SLPG and SGPG in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 1996, 70:1-6.